Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Arachidonic acid catabolism, specifically through the prostaglandin synthesis pathway, is the enzymatic conversion of arachidonic acid into prostaglandins. This process is central to inflammation, vascular homeostasis, and many physiological responses. The pathway involves the release of arachidonic acid by phospholipase A2, followed by conversion via cyclooxygenases (COX-1 and COX-2) and terminal synthases into various prostaglandins, each with distinct biological effects. Dysregulation is implicated in diseases like arthritis, cardiovascular disease, and cancer.
Inhibition of cyclooxygenase (COX) enzymes, blocking prostaglandin production.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Arachidonic Acid Catabolism (Prostaglandin Synthesis).